Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

NCT00267358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Cancer Cachexia

Interventions

DRUG: RC-1291 HCl
DRUG: Placebo

Sponsor

Helsinn Therapeutics (U.S.), Inc